CCR7 is a chemokine receptor that binds ligands CCL19 and CCL21, driving lymphocyte migration and cancer metastasis. Overexpression in cancers (e.g., breast, melanoma) correlates with poor prognosis due to enhanced lymph node metastasis .
A synthetic M13 phage library was used to isolate single-chain variable fragments (scFvs) against purified CCR7. Key steps included:
Antigen Preparation: CCR7 stabilized in its active conformation .
Screening: 384 clones screened via ELISA, yielding 7 CCR7-specific scFvs .
| Stage | Number of Clones |
|---|---|
| Initial screening (ELISA) | 384 |
| Primary hits | 50 |
| Unique clones | 16 |
| CCR7-specific clones | 7 |
| Ligand-competitive clones | 2 (6RG11, 72C7) |
Selected scFvs (6RG11, 72C7) were converted to IgG4 formats to minimize effector functions. Both exhibited:
Migration Inhibition: Both antibodies reduced CCR7+ cell migration by 60–80% in transwell assays .
Antagonism: IgG4(6RG11) suppressed CCR7-mediated cAMP attenuation, confirming receptor antagonism .
Metastasis Blockade: Antibodies inhibited invasion of CCR7+ cancer cells in vitro .
Synergy with Radiotherapy: Radiolabeled anti-CCR7 antibodies (e.g., -ch806) showed tumor-specific uptake in xenografts .
CHO Cell Lines: Overexpression of HsQSOX1b and survivin enhanced antibody yield (2x increase) by improving disulfide bond folding and reducing apoptosis .
Safety Profile: Phase I trials of analogous anti-EGFR antibodies (e.g., HLX07) demonstrated tolerability up to 800 mg/week, with no dose-limiting toxicities .
Therapeutic Potential: CCR7 antibodies are candidates for metastatic cancer treatment, with ongoing focus on improving tumor retention and reducing off-target effects .
Antigen Characterization: High-throughput antibody generation programs (e.g., EU Affinomics) highlight the need for rigorous validation in Western blotting, immunofluorescence, and KO cell lines .
Scalability: Stable CHO cell lines remain critical for industrial production, though heterogeneity in antibody expression persists .
CHX7 (Cation/H+ Exchanger 7) is a protein found in Arabidopsis thaliana (Mouse-ear cress), identified by UniProt accession number Q9ZUV9 . It belongs to the CHX family of transporters that are involved in cation homeostasis and pH regulation in plant cells. The CHX7 Antibody is a research tool used to detect and study this protein in plant tissue samples. Understanding CHX7's function is important for plant physiology research, particularly in studies related to ion transport and stress responses in plants.
The CHX7 Antibody is specifically designed to recognize and bind to the CHX7 protein in Arabidopsis thaliana. Unlike more generic antibodies, the CHX7 Antibody (product code CSB-PA138789XA01DOA) has been developed with high specificity for this particular plant protein . When comparing antibody options, researchers should consider the following factors that distinguish CHX7 Antibody from other plant protein antibodies:
| Feature | CHX7 Antibody | General Plant Antibodies |
|---|---|---|
| Target specificity | Specific to CHX7 protein | May target broader protein families |
| Host organism | Based on manufacturer design | Various (mouse, rabbit, goat, etc.) |
| Applications | Western blot, IHC, ICC, ELISA (depending on validation) | Various, depending on antibody |
| Species reactivity | Primarily Arabidopsis thaliana | May cross-react with multiple plant species |
When selecting antibodies for plant research, validation in the specific experimental system is critical to ensure accurate results.
While specific protocols for CHX7 Antibody are not detailed in the search results, researchers can adapt standard antibody protocols with optimization for plant samples. Based on established immunoassay techniques, the following methodological approach is recommended:
For Western Blot analysis:
Extract proteins from Arabidopsis tissue using an appropriate plant protein extraction buffer
Separate proteins by SDS-PAGE and transfer to a PVDF membrane
Block the membrane using 5% non-fat milk or BSA in PBST
Incubate with CHX7 Antibody at an optimized dilution (typically starting at 1:1000)
Wash thoroughly with PBST
Incubate with appropriate secondary antibody
For immunofluorescence in plant tissues, researchers may need to adapt protocols similar to those used for other antibodies, including proper fixation of plant tissues and optimization of antibody concentration . Always include appropriate positive and negative controls to ensure specificity and reduce background.
Proper storage and handling of CHX7 Antibody is crucial for maintaining its activity and specificity. Although specific information for CHX7 Antibody is not provided in the search results, standard antibody handling protocols should be followed:
Store the antibody at -20°C for long-term storage or at 4°C for short-term (1-2 weeks) use
Avoid repeated freeze-thaw cycles by aliquoting the antibody upon first thaw
Work with the antibody on ice when preparing dilutions
Use sterile techniques to prevent contamination
Follow manufacturer's recommendations for buffer compatibility
Check for precipitation before use and centrifuge if necessary
Verify expiration dates and lot-to-lot consistency when performing critical experiments
Improper storage can lead to antibody degradation, resulting in reduced sensitivity and increased background in experimental applications.
Although the names appear similar, CHX7 Antibody and the CHX Chase Assay are distinct research tools with different applications. The CHX7 Antibody targets the CHX7 plant protein , whereas the CHX (Cycloheximide) Chase Assay refers to a technique using cycloheximide, a small molecule derived from Streptomyces griseus that inhibits protein synthesis in eukaryotes .
The CHX Chase Assay is used to study protein degradation and determine protein half-life by blocking new protein synthesis and monitoring the disappearance of existing proteins over time . This technique is widely recognized for observing intracellular protein degradation in eukaryotes. On the other hand, CHX7 Antibody is used to detect and study the specific CHX7 protein in plant samples.
The confusion between these tools highlights the importance of clear terminology in research discussions and publications.
Validating antibody specificity is critical for ensuring reliable experimental results. For CHX7 Antibody research in Arabidopsis, several validation strategies should be employed:
Genetic controls: Compare antibody labeling between wild-type plants and chx7 knockout/knockdown mutants. Absence or significant reduction of signal in mutants strongly supports antibody specificity.
Peptide competition assay: Pre-incubate the antibody with excess purified CHX7 protein or the immunizing peptide before application to samples. Specific binding should be blocked, resulting in signal reduction.
Western blot molecular weight verification: The detected band should match the predicted molecular weight of CHX7 protein. Multiple or unexpected bands may indicate cross-reactivity.
Mass spectrometry validation: Immunoprecipitate proteins using the CHX7 Antibody and analyze by mass spectrometry to confirm the identity of captured proteins.
Orthogonal detection methods: Correlate antibody results with mRNA expression data or protein tagged with fluorescent markers.
These validation steps should be documented and reported in publications to enhance reproducibility across research laboratories.
Optimizing immunoprecipitation (IP) with CHX7 Antibody requires careful consideration of several parameters to ensure specific and efficient protein capture:
Lysis buffer optimization: Plant tissues require specialized lysis buffers that effectively solubilize membrane proteins like CHX7 while preserving protein-protein interactions. Test different detergent concentrations (0.1-1% NP-40, Triton X-100, or digitonin) and salt concentrations (100-300 mM NaCl).
Crosslinking considerations: For transient or weak interactions, consider mild crosslinking with formaldehyde (0.1-1%) or DSP (dithiobis(succinimidyl propionate)) before cell lysis.
Antibody coupling: For cleaner results, couple the CHX7 Antibody to protein A/G beads or magnetic beads before immunoprecipitation rather than adding it directly to lysates.
IP conditions optimization: Test various antibody concentrations, incubation times (2 hours vs. overnight), and temperatures (4°C vs. room temperature) to identify conditions that maximize specific interactions while minimizing non-specific binding.
Washing stringency: Optimize wash buffer composition by adjusting salt and detergent concentrations to remove non-specific interactions while preserving true interactions.
Elution methods: Compare different elution strategies (glycine pH 2.5, SDS, competitive peptide elution) to identify the most effective approach for your specific interaction study.
Successful optimization should be validated by detecting known interaction partners or by reciprocal co-immunoprecipitation experiments.
When encountering weak or inconsistent signals with CHX7 Antibody in Western blots, researchers should systematically evaluate and optimize each step of the protocol:
Sample preparation optimization:
Ensure complete tissue disruption and efficient protein extraction
Test different extraction buffers optimized for membrane proteins
Include protease inhibitors to prevent degradation
Optimize protein loading (10-50 μg total protein)
Transfer efficiency improvement:
Adjust transfer conditions for membrane proteins (longer transfer times, addition of SDS)
Verify transfer efficiency using reversible protein stains (Ponceau S)
Consider using PVDF membrane instead of nitrocellulose for higher protein binding capacity
Blocking optimization:
Test different blocking agents (5% milk, 5% BSA, commercial blocking buffers)
Adjust blocking time and temperature
Antibody incubation parameters:
Test a range of primary antibody dilutions (1:500 to 1:5000)
Extend primary antibody incubation time (overnight at 4°C)
Optimize secondary antibody concentration and incubation time
Signal enhancement strategies:
Use high-sensitivity detection reagents
Consider signal amplification systems
Extend film exposure time or adjust imaging settings
Protein abundance considerations:
Confirm CHX7 expression levels in your specific tissue/conditions
Consider protein enrichment through subcellular fractionation or immunoprecipitation before Western blotting
Systematic documentation of optimization steps will help identify the critical parameters affecting CHX7 detection.
Understanding the tissue-specific and developmental expression patterns of CHX7 is essential for designing appropriate experiments. While specific data on CHX7 expression is not provided in the search results, researchers can implement the following methodological approach to characterize expression patterns:
Tissue-specific Western blot analysis:
Collect various tissues (roots, stems, leaves, flowers, seeds) at different developmental stages
Prepare protein extracts using standardized protocols
Perform Western blot analysis using CHX7 Antibody
Quantify relative protein levels normalized to appropriate loading controls
Immunohistochemistry for spatial localization:
Fix plant tissues using paraformaldehyde
Section tissues and perform immunostaining with CHX7 Antibody
Counter-stain with organelle-specific markers to determine subcellular localization
Image using confocal microscopy for high-resolution localization data
Correlation with transcriptomic data:
Compare protein expression patterns with publicly available RNA-seq data from databases like TAIR or BAR
Validate key findings with RT-qPCR analysis of CHX7 mRNA
Environmental and stress response analysis:
Evaluate CHX7 expression under various stress conditions (drought, salt, temperature)
Monitor expression changes during diurnal cycles
This comprehensive approach provides insights into both the spatial and temporal regulation of CHX7 expression, informing experimental design and interpretation of functional studies.
Designing robust experiments to study CHX7 protein-protein interactions in plant systems requires careful planning and multiple complementary approaches:
In vivo interaction detection systems:
Split-ubiquitin yeast two-hybrid systems (optimized for membrane proteins)
Bimolecular Fluorescence Complementation (BiFC) in plant protoplasts or stable transgenic lines
Förster Resonance Energy Transfer (FRET) with fluorescently tagged proteins
Proximity-dependent biotin identification (BioID) adapted for plant systems
Co-immunoprecipitation strategies:
Generate epitope-tagged CHX7 constructs (FLAG, HA, GFP) for expression in planta
Use CHX7 Antibody for endogenous protein immunoprecipitation
Apply stringent controls including non-specific antibodies and knockout lines
Analyze precipitated proteins by mass spectrometry for unbiased interaction discovery
Biological validation of interactions:
Genetic interaction studies comparing single and double mutants
Co-localization analysis using confocal microscopy
Functional complementation experiments with mutated interaction interfaces
Membrane protein-specific considerations:
Optimize detergent conditions to solubilize membrane proteins while preserving interactions
Consider covalent crosslinking to capture transient interactions
Evaluate the effect of artificial environments on membrane protein behavior
Data integration and analysis:
Combine results from multiple techniques to build confidence in interactions
Use computational approaches to predict interaction interfaces
Place identified interactions in the context of known protein networks
By employing multiple complementary approaches and rigorous controls, researchers can obtain reliable insights into CHX7 protein interaction networks.
Future research on CHX7 would benefit from integrated approaches combining antibody-based protein detection with genetic manipulation and functional assays. Developing new tools such as phospho-specific antibodies or conformation-specific antibodies could provide deeper insights into CHX7 regulation and function in plant systems. Additionally, applying emerging technologies like proximity labeling and single-cell proteomics may reveal new aspects of CHX7 biology that are not accessible with current methods.